Details for Patent: 11,541,002
✉ Email this page to a colleague
Which drugs does patent 11,541,002 protect, and when does it expire?
Patent 11,541,002 protects SYMPAZAN and is included in one NDA.
This patent has six patent family members in six countries.
Drugs Protected by US Patent 11,541,002
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-001 | Nov 1, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING SEIZURES | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-002 | Nov 1, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING SEIZURES | ⤷ Sign Up | |||
Otter Pharms | SYMPAZAN | clobazam | FILM;ORAL | 210833-003 | Nov 1, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING SEIZURES | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,541,002
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | 112021004053 | ⤷ Sign Up | |||
Canada | 3110997 | ⤷ Sign Up | |||
China | 112955124 | ⤷ Sign Up | |||
European Patent Office | 3846778 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |